Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double‐blind, methotrexate‐controlled study of patients with active rheumatoid arthritis
Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Arthritis & Rheumatism
DOI: 10.1002/art.24266
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2132049460
